Literature DB >> 18209063

The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity.

Alicia Klatt1, Zhiqiang Zhang, Parisa Kalantari, Pamela A Hankey, David S Gilmour, Andrew J Henderson.   

Abstract

Efficient HIV-1 transcription requires the induction of cellular transcription factors, such as NF-kappaB, and the viral factor Tat, which through the recruitment of P-TEFb enhances processive transcription. However, whether cellular signals repress HIV-1 transcription to establish proviral latency has not been well studied. Previously, it has been shown that the receptor tyrosine kinase RON inhibits HIV transcription. To gain insights into the biochemical mechanisms by which RON inhibits transcription we examined the binding of transcription factors to the HIV provirus long terminal repeat using chromatin immunoprecipitation. RON expression decreased basal levels of NF-kappaB and RNA polymerase II (Pol II) binding to the HIV provirus long terminal repeat but did not prevent the induction of these complexes following treatment with cytokines. However, RON did decrease efficient transcription elongation because reduced RNA Pol II was associated with HIV-1 genomic sequences downstream of the transcriptional start site. There was a correlation between RON expression and increased binding of factors that negatively regulate transcription elongation, NELF, Spt5, and Pcf11. Furthermore, the ability of RON to inhibit HIV-1 transcription was sensitive to a histone deacetylase inhibitor and was associated with nucleosome remodeling. These results indicate that RON represses HIV transcription at multiple transcriptional check points including initiation, elongation and chromatin organization and are the first studies to show that cellular signaling pathways target Pol II pausing to repress gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209063     DOI: 10.4049/jimmunol.180.3.1670

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.

Authors:  Alexandra Duverger; Frank Wolschendorf; Mingce Zhang; Fredric Wagner; Brandon Hatcher; Jennifer Jones; Randall Q Cron; Renee M van der Sluis; Rienk E Jeeninga; Ben Berkhout; Olaf Kutsch
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

Review 3.  Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Authors:  Vicente Planelles; Frank Wolschendorf; Olaf Kutsch
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

Review 4.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

5.  Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.

Authors:  Alexandra Duverger; Frank Wolschendorf; Joshua C Anderson; Frederic Wagner; Alberto Bosque; Takao Shishido; Jennifer Jones; Vicente Planelles; Christopher Willey; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

6.  Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.

Authors:  Takao Shishido; Frank Wolschendorf; Alexandra Duverger; Frederic Wagner; John Kappes; Jennifer Jones; Olaf Kutsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

7.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 8.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

9.  HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation.

Authors:  Parisa Kalantari; Omid F Harandi; Pamela A Hankey; Andrew J Henderson
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

10.  Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription.

Authors:  Manuela Vanti; Edurne Gallastegui; Iñaki Respaldiza; Alfonso Rodríguez-Gil; Fernando Gómez-Herreros; Silvia Jimeno-González; Albert Jordan; Sebastián Chávez
Journal:  PLoS Genet       Date:  2009-01-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.